This Week's Healthcare Earnings: Tariffs Galore
Tariffs were, unsurprisingly, a major theme on investor calls this past week, as around a dozen healthcare companies released their quarterly financials and kicked off the thick of the earnings season for the industry.
Eli Lilly Opens New Front Against Weight-Drug Compounders
Pharma giant Eli Lilly is taking a new tack in its efforts to protect its lucrative weight-loss drugs by raising allegations that telehealth competitors are engaged in illegal corporate practice of medicine.
HHS Legal Staff Cuts Will Impair Abuse, Neglect Enforcement
A massive overhaul underway at the U.S. Department of Health and Human Services will wipe out the roles filled by more than 100 attorneys and other staff at offices in six states. Among the enforcement areas being hit are federal efforts led by regional HHS legal teams combating elder abuse and neglect at nursing homes.
This Week's Healthcare Earnings: Tariffs Galore
Tariffs were, unsurprisingly, a major theme on investor calls this past week, as around a dozen healthcare companies released their quarterly financials and kicked off the thick of the earnings season for the industry.
Eli Lilly Opens New Front Against Weight-Drug Compounders
Pharma giant Eli Lilly is taking a new tack in its efforts to protect its lucrative weight-loss drugs by raising allegations that telehealth competitors are engaged in illegal corporate practice of medicine.
HHS Legal Staff Cuts Will Impair Abuse, Neglect Enforcement
A massive overhaul underway at the U.S. Department of Health and Human Services will wipe out the roles filled by more than 100 attorneys and other staff at offices in six states. Among the enforcement areas being hit are federal efforts led by regional HHS legal teams combating elder abuse and neglect at nursing homes.
Expert Analysis
The Seventh Circuit's recent decision in U.S. v. Sorensen, reversing a conviction after trial of a durable medical... (more story)
Two recent executive orders issued by President Donald Trump regarding gender-affirming care for minors have put h... (more story)
.jpg)
Based on priorities stated so far, the Trump administration will likely continue to weaken Biden-era policies that... (more story)
Deals & Corporate Governance More
Investors suing behavioral health care provider Acadia Healthcare Co. have asked a federal judge to find that they relied on certain alleged misrepresentations before investing in the company after previously ... (more story)
Executives of healthcare real estate investment trust Welltower on Tuesday touted the company's work closing more acquisitions during this year's first quarter than it did in all of 2024, ahead of expected eco... (more story)
Latham & Watkins LLP has welcomed back an intellectual property attorney who spent the past nine years at Cooley LLP to bolster its healthcare and life sciences practice, including advising clients about licen... (more story)
Amanda Copsey, a longtime U.S. Department of Health and Human Services' Office of Inspector General attorney, has joined Baker Donelson Bearman Caldwell & Berkowitz PC as a shareholder in its Baltimore office,... (more story)
Sanofi-Aventis U.S. LLC on Monday sought to exit nine combined Connecticut lawsuits claiming the heartburn drug ranitidine degraded into a compound that causes cancer, saying it is beyond the state's long-arm ... (more story)
Merck KGaA said Monday it has agreed to acquire U.S. biotech company SpringWorks Therapeutics for $3.9 billion, as the German science and technology group aims to grow its cancer drug business and its global presence.
Digital Health & Technology More
The Fourth Circuit has declined an electronic medical records firm's request for the appellate court to rethink a panel's decision to dismiss its appeal of an order forcing the company to let a nursing data bu... (more story)
A recent Texas federal court decision vacating the U.S. Food and Drug Administration's final rule that would apply FDA regulations to laboratory-developed tests signals potential positive impacts in the diagno... (more story)
A group of pediatric dental practices in North Carolina have accused their longtime business consultant of "hijacking" several website domains after they canceled his contract, saying he's trying to use the do... (more story)
A Washington state-based diagnostic testing services provider for Planned Parenthood has been hit with a pair of proposed class actions in Seattle federal court over an October data breach that reportedly impa... (more story)
The Ninth Circuit on Thursday revived a patient's allegations that C.R. Bard's blood clot-preventing IVC filter was defective, ruling that a lower court was wrong to throw out the suit as untimely since there ... (more story)
Blue Shield of California was slapped with a putative class action in California state court Monday, days after the health insurer announced that the personal data of some of its patients had been "impermissib... (more story)
Policy & Compliance More
The U.S. Department of Justice told the 11th Circuit on Wednesday that a Florida federal judge was wrong to rule that the provision of the False Claims Act that lets whistleblowers bring suits on the governmen... (more story)
SuperValu urged an Illinois federal judge Tuesday not to overturn its defense win on whistleblower claims of systematic prescription overbilling, saying the whistleblowers are now making "kitchen sink argument... (more story)
An Atlanta home healthcare service was hit with a proposed class action Wednesday over allegations it failed to pay certified nursing assistants proper overtime compensation.
The U.S. Department of Labor and the U.S. Department of Health and Human Services challenged a bid to halt agencies from giving Elon Musk's Department of Government Efficiency access to sensitive systems, tell... (more story)
A California federal judge has dismissed a proposed class action alleging Thang Botanicals and FTLS Holdings LLC mislead consumers about addictive qualities of their kratom products after the plaintiffs failed... (more story)
Gilead agreed to pay $202 million to the federal government and some states to resolve claims it made improper payments to high-volume prescribers of its HIV drugs, New York federal prosecutors announced Tuesday.